Antibody cocktail effective against variants of SARS-CoV-2

被引：0
|
作者：
Kang-Hao Liang
Pao-Yin Chiang
Shih-Han Ko
Yu-Chi Chou
Ruei-Min Lu
Hsiu-Ting Lin
Wan-Yu Chen
Yi-Ling Lin
Mi-Hua Tao
Jia-Tsrong Jan
Han-Chung Wu
机构：
[1] Academia Sinica,Biomedical Translation Research Center (BioTReC)
[2] Academia Sinica,Institute of Cellular and Organismic Biology
[3] Academia Sinica,Institute of Biomedical Sciences
[4] Academia Sinica,Genomics Research Center
来源：
Journal of Biomedical Science | / 28卷
关键词：
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Receptor-binding domain (RBD); Neutralizing antibody; Cocktail therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] In vitro activity of cysteamine against SARS-CoV-2 variants
    Thoene, Jess
    Gavin, Robert F.
    Towne, Aaron
    Wattay, Lauren
    Ferrari, Maria Grazia
    Navarrete, Jennifer
    Pal, Ranajit
    MOLECULAR GENETICS AND METABOLISM, 2022, 137 (1-2) : 192 - 200
  • [42] Genetic Variants and Protective Immunity against SARS-CoV-2
    Rabaan, Ali A.
    Al Mutair, Abbas
    Aljeldah, Mohammed
    Al Shammari, Basim R.
    Sulaiman, Tarek
    Alshukairi, Abeer N.
    Alfaresi, Mubarak
    Al-Jishi, Jumana M.
    Al Bati, Neda A.
    Al-Mozaini, Maha A.
    Bshabshe, Ali Al
    Almatouq, Jenan A.
    Abuzaid, Abdulmonem A.
    Alfaraj, Amal H.
    Al-Adsani, Wasl
    Alabdullah, Mohammed
    Alwarthan, Sara
    Alsalman, Fatimah
    Alwashmi, Ameen S. S.
    Alhumaid, Saad
    GENES, 2022, 13 (12)
  • [43] Kinetics of neutralising antibodies against SARS-CoV-2 variants
    Poletti, Piero
    LANCET INFECTIOUS DISEASES, 2025, 25 (01): : 8 - 9
  • [44] Screening for inhibitors against SARS-CoV-2 and its variants
    Yuan Weijing
    Dong Xiaojing
    Chen Lan
    Lei Xiaobo
    Zhou Zhuo
    Guo Li
    Wang Jianwei
    生物安全与健康（英文）, 2022, 04 (03) : 186 - 192
  • [45] Screening for inhibitors against SARS-CoV-2 and its variants
    Yuan, Weijing
    Dong, Xiaojing
    Chen, Lan
    Lei, Xiaobo
    Zhou, Zhuo
    Guo, Li
    Wang, Jianwei
    BIOSAFETY AND HEALTH, 2022, 4 (03) : 186 - 192
  • [46] Broadly neutralizing antibodies against SARS-CoV-2 variants
    Linqi Zhang
    NationalScienceOpen, 2022, 1 (01) : 24 - 31
  • [47] Are the new SARS-CoV-2 variants resistant against the vaccine?
    Abdalla, Mohnad
    El-Arabey, Amr Ahmed
    Jiang, Xinyi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (10) : 3489 - 3490
  • [48] Vaccines against SARS-CoV-2 variants and future pandemics
    Park, Taeyoung
    Hwang, Hyogyeong
    Moon, Suhyeong
    Kang, Sang Gu
    Song, Seunghyup
    Kim, Young Hun
    Kim, Hanbi
    Ko, Eun-Ju
    Yoon, Soon-Do
    Kang, Sang-Moo
    Hwang, Hye Suk
    EXPERT REVIEW OF VACCINES, 2022, 21 (10) : 1363 - 1376
  • [49] Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
    Teli, Divya
    Balar, Pankti
    Patel, Kishan
    Sharma, Anu
    Chavda, Vivek
    Vora, Lalit
    METABOLITES, 2023, 13 (02)
  • [50] High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV
    Sasaki, Hiroaki
    Miyata, Nobuyuki
    Yoshimura, Yukihiro
    Tachikawa, Natsuo
    INFECTION, 2022, 50 (03) : 771 - 774
12345